Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,405 USD | -1,06% | +1,81% | -87,07% |
17/04 | MARINUS PHARMACEUTICALS, INC. : Truist Securities geeft koopadvies | ZM |
16/04 | MARINUS PHARMACEUTICALS, INC. : Baird herziet opinie en gaat over naar Neutraal | ZM |
Vakgebied
Aantal werknemers: 166
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics for Rare Seizures
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05-09-18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12-04-21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-11-19 |
Chief Tech/Sci/R&D Officer | - | - | |
Sonya Weigle
IRO | Public Communications Contact | - | 01-09-21 |
Christy Shafer
PRN | Corporate Officer/Principal | 48 | 10-11-20 |
General Counsel | - | - | |
Thomas Lyons
PRN | Corporate Officer/Principal | - | 01-01-18 |
Alex Aimetti
PRN | Corporate Officer/Principal | - | - |
Martha Manning
LAW | General Counsel | 69 | 15-06-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01-12-08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05-09-18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12-12-19 |
Seth Fischer
BRD | Director/Board Member | 68 | 06-09-16 |
Sara Nochur
BRD | Director/Board Member | 63 | 22-03-21 |
Sarah Noonberg
BRD | Director/Board Member | 56 | 16-05-23 |
Director/Board Member | 41 | 26-01-23 | |
Charles Austin
BRD | Director/Board Member | 68 | 29-07-20 |
Marvin Johnson
BRD | Director/Board Member | 61 | 18-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 938 349 | 54 400 357 ( 99,02 %) | 7 307 ( 0,0133 %) | 99,02 % |
Bedrijfsgegevens
Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center 100 Matsonford Road
19087-5279, Radnor
+484 801 4670
http://www.marinuspharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-87,07% | 77,17 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers MRNS
- Onderneming Marinus Pharmaceuticals, Inc.